Molecular basis for the loss-of-function effects of the Alzheimer's disease–associated R47H variant of the immune receptor TREM2
2018 · Journal of Biological Chemistry · 146 citations
https://doi.org/10.1074/jbc.ra118.002352
I
Ian N. Foltz
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
59
Papers
3.2K
Citations
24
h-index
28
i10-index
Ian N. Foltz is an academic researcher from Amgen (United States). The author has contributed to research in topics: Monoclonal and Polyclonal Antibodies Research & Radiopharmaceutical Chemistry and Applications & Cell Adhesion Molecules Research. The author has an h-index of 24, co-authored 51 publications.
Papers by this author
worksThe p38 mitogen-activated protein kinase is activated by ligation of the T or B lymphocyte antigen receptors, Fas or CD40, but suppression of kinase activity does not inhibit apoptosis induced by antigen receptors
1997 · The Journal of Immunology · 87 citations
https://doi.org/10.4049/jimmunol.159.11.5309
Asymmetrical Fc Engineering Greatly Enhances Antibody-dependent Cellular Cytotoxicity (ADCC) Effector Function and Stability of the Modified Antibodies
2013 · Journal of Biological Chemistry · 72 citations
https://doi.org/10.1074/jbc.m113.513366
Analytical and Functional Similarity of Aflibercept Biosimilar ABP 938 with Aflibercept Reference Product
2024 · Ophthalmology and Therapy · 3 citations
https://doi.org/10.1007/s40123-024-00914-1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat